Marvell (MRVL) Recovery Real, Margin and EPS Outlook Above Consensus

Marvell (MRVL), a global semiconductor provider, has rebounded strongly in recent weeks, and Citi sees this continuing:

In the 2+ wks since the [company’s] F1Q09 beat and raise, incoming calls [from investors] have spiked, focused on product cycles, margins and ultimately earnings power. We conclude a) product cycles are broader then the Street perceives, b) margin improvement is earlier and incremental to prior expectations, and c) the earnings inflection is structural w/upside potential.

Citi maintains BUY, target price $22.

See Also:
Marvell: FBR Raises Target After Blowout Q1

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at